Table 1.

Prosthetic device infection cases diagnosed by FDG-PET-CT in CHD (congenital heart disease).

No.	Investigator	Age (y)	Sex	CHD	Position	SUV max	Bacteria	Initial TTE	Therapy	Surgery
1	Roque et al. (5)	48	M	TOF	Bioprosthetic pulmonary valve	8.04	Unknown	Negative	Unknown	Unknown
2	Zhang et al. (7)	9	F	TOF	Pulmonary conduit	4.2	MRSA	Positive	Antibiotic	Conduit replacement
3	Meyer et al. (30)	11	M	TOF	Pulmonary conduit valve	Unknown	Staphylococcus aureus	Positive	Antibiotic	None
4	Meyer et al. (30)	55	F	TOF	Pulmonary conduit valve	Unknown	Staphylococcus aureus	Negative	Antibiotics	Conduit replacement
5	Meyer et al. (30)	17	F	TOF	Pulmonary conduit valve	Unknown	Staphylococcus capitis	Negative	Antibiotics	None
6	Meyer et al. (30)	8	F	TAC	Pulmonary conduit	Unknown	Lactobazillus rhamnosus	Negative	Antibiotics	None
7	Meyer et al. (30)	22	F	TOF	Pulmonary conduit	Unknown	Negative	Negative	Antibiotics	None

TTE, transesophageal echocardiography; TOF, tetralogy of Fallot; TAC, Truncus arteriosus; MRSA, methicillin resistant Staphylococcus aureus.